260 related articles for article (PubMed ID: 4759241)
1. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Palmer HM
Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
[No Abstract] [Full Text] [Related]
2. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
Tobias H; Auerbach R
Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
[No Abstract] [Full Text] [Related]
3. Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
Weinstein GD; Cox JW; Suringa DW; Millard MM; Kalser M; Frost P
Arch Dermatol; 1970 Dec; 102(6):613-8. PubMed ID: 5501902
[No Abstract] [Full Text] [Related]
4. Liver injury associated with methotrexate therapy for psoriasis.
Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA
Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150
[No Abstract] [Full Text] [Related]
5. Methotrexate induced liver disease in psoriasis.
Millward-Sadler GH; Ryan TJ
Br J Dermatol; 1974 Jun; 90(6):661-7. PubMed ID: 4853200
[No Abstract] [Full Text] [Related]
6. Liver disease in psoriatics--An effect of methotrexate therapy?
Shapiro HA; Trowbridge JO; Lee JC; Maibach HI
Arch Dermatol; 1974 Oct; 110(4):547-51. PubMed ID: 4414499
[No Abstract] [Full Text] [Related]
7. Detection of hepatotoxicity associated with methotrexate therapy for psoriasis.
O'Connor GT; Olmstead EM; Zug K; Baughman RD; Beck JR; Dunn JL; Seal P; Lewandowski JF
Arch Dermatol; 1989 Sep; 125(9):1209-17. PubMed ID: 2774596
[TBL] [Abstract][Full Text] [Related]
8. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
Zachariae H; Grunnet E; Sogaard H
Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
[TBL] [Abstract][Full Text] [Related]
9. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Roenigk HH; Bergfeld WF; St Jacques R; Owens FJ; Hawk WA
Arch Dermatol; 1971 Mar; 103(3):250-61. PubMed ID: 5548272
[No Abstract] [Full Text] [Related]
10. Psoriasis-liver-methotrexate interactions.
Arch Dermatol; 1973 Jul; 108(1):36-42. PubMed ID: 4716740
[No Abstract] [Full Text] [Related]
11. Drug reactions XV. Methotrexate, psoriasis and the liver.
Almeyda J; Barnardo D; Baker H
Br J Dermatol; 1971 Sep; 85(3):302-5. PubMed ID: 4939241
[No Abstract] [Full Text] [Related]
12. Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment.
Zachariae H; Kragballe K; Søgaard H
Br J Dermatol; 1980 Apr; 102(4):407-12. PubMed ID: 7387883
[No Abstract] [Full Text] [Related]
13. Structural and functional abnormalities of the liver in psoriasis before and during methotrexate therapy.
Almeyda J; Barnardo D; Baker H; Levene GM; Landells JW
Br J Dermatol; 1972 Dec; 87(6):623-31. PubMed ID: 4648805
[No Abstract] [Full Text] [Related]
14. [Liver biopsy studies in long-term therapy of psoriasis using methotrexate].
Dietz O; Pachaly A; Schillat I
Dermatol Monatsschr; 1974 Aug; 160(8):634-42. PubMed ID: 4216519
[No Abstract] [Full Text] [Related]
15. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis.
Ashton RE; Millward-Sadler GH; White JE
J Invest Dermatol; 1982 Oct; 79(4):229-32. PubMed ID: 7130740
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate therapy for psoriasis. Guideline revisions.
Roenigk HH; Maibach HI; Weinstein GP
Arch Dermatol; 1973 Jul; 108(1):35. PubMed ID: 4716739
[No Abstract] [Full Text] [Related]
17. Longterm methotrexate therapy in rheumatoid arthritis: a review.
Kremer JM
J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
[TBL] [Abstract][Full Text] [Related]
18. [Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].
Moldenhauer E; Dabels J; Diwok K; Leithäuser W; Nowotny P
Dermatol Monatsschr; 1973 Mar; 159(3):242-8. PubMed ID: 4704945
[No Abstract] [Full Text] [Related]
19. Effects of methotrexate on the liver in psoriasis.
Reese LT; Grisham JW; Aach RD; Eisen AZ
J Invest Dermatol; 1974 Jun; 62(6):597-602. PubMed ID: 4835782
[No Abstract] [Full Text] [Related]
20. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
Lanse SB; Arnold GL; Gowans JD; Kaplan MM
Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]